Leading cement makers reported strong double-digit year-on-year growth in sales volumes during the December 2025 quarter, even as their realisations came under pressure. The companies remain optimistic of further improvement in demand and prices in the coming months, aided by benign inflation, supportive tax rationalisation measures and healthy infrastructure-led growth. Industry leaders, including UltraTech, Ambuja Cements, Shree Cement, Dalmia Bharat, JK Lakshmi Cement and JSW Cement, saw higher capacity utilisation and expansion in volumes. However, overall profitability was impacted by rising input costs, provisions under new labour codes and elevated prices of pet coke and coal. Despite these challenges, toplines were supported by premiumisation, improved product mix and higher non-trade sales. Apart from grey cement, companies also reported robust growth in their Ready Mix Concrete (RMC) business, which registered high double-digit expansion. Leading cement maker UltraTech .
JSW Cement rose as much as 9.3 per cent to ₹127, the highest level since November 20, 2025 on the National Stock Exchange (NSE) in Thursday's intra-day trade.
JSW Cement Ltd has reported a profit of Rs 130.62 crore for the December quarter of FY26, helped by improvement in EBITDA and gains in sales volume. The company had reported a loss of Rs 80.22 crore for the October-December quarter a year ago, according to a regulatory filing from JSW Cement, part of the USD 23 billion JSW group, on late Wednesday evening. JSW Cement has reported an exceptional item (net loss) of Rs 33.66 crore in the December quarter, mainly due to the implementation of the new Labour Codes. Its profit before exceptional items and tax was at Rs 217.95 crore in the quarter under review. Revenue from operations of the company was up 13.15 per cent to Rs 1,621.22 crore in the December quarter of FY26 on a year to year basis. It was at Rs 1,432.74 crore in the corresponding quarter a year ago. Its revenue increases "primarily driven by volume increase," said JSW Cement in its earnings presentations. Its "Operating EBITDA improved 31.5 per cent YoY to Rs 285.1 crore,
Stocks to Watch today, February 5, 2026: Medanta, JSW Cement, Cummins India, Emcure Pharma, Bajaj Finserv, Metropolis, Emami, Lupin, and NHPC are among the top stocks to watch today
The brokerage has an 'Accumulate' rating on JK Cement for a target of ₹6,173 per share; 'Buy' rating on both JK Lakshmi and JSW Cement with a target of ₹891 and ₹143, respectively
The year 2025 has seen over 100 mainboard, and 250+ SME IPOs. From frenzied demand to aggressive pricing among others, here are the key learnings from IPO investing as per experts.
According to Shrikant Chouhan of Kotak Securities, Thermax strong earnings prospects and JSW Cement capacity expansion plans augur well for these two stocks.
Stocks to Watch Today, November 18, 2025: Tata Power Company, TVS Motor Company, Emcure Pharma, AstraZeneca Pharma, JSW Energy, JSW Cement, and WPIL are among the top stocks to remain in spotlight
Stocks to Watch today: Nykaa, Torrent Pharma, Trent, JSW Cement, Swiggy, Concor and Havells India are among the stocks to watch today, November 10, 2025
The cement maker reversed its previous quarter loss, supported by a 17% rise in revenue and higher volumes, even as expansion projects continued across India
Shares of JSW Cement hit a record low of ₹129, and traded at a 12 per cent discount compared to issue price of ₹147 per share.
JSW Cement reported a Q1 FY26 loss of Rs 1,356.17 crore due to a one-time CCPS conversion, even as revenue rose 7.77 per cent and operating Ebitda improved 39 per cent YoY
The company had reported a profit before exceptional items and tax of Rs 8.14 crore for the April-June quarter a year ago